Items where authors include "Paneesha, S."

Article

Munir, T., Cairns, D.A. orcid.org/0000-0002-2338-0179, Bloor, A. et al. (29 more authors) (2023) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. New England Journal of Medicine. ISSN 0028-4793

Hillmen, P., Pitchford, A., Bloor, A. et al. (29 more authors) (2023) Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 24 (5). pp. 535-552. ISSN 1470-2045

Waszczuk-Gajda, A., Gras, L., de Wreede, L.C. orcid.org/0000-0002-7667-9369 et al. (22 more authors) (2023) Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients—the DIADEM study from the chronic malignancies working party of the EBMT. Bone Marrow Transplantation. pp. 1-6. ISSN 0268-3369

Kaparou, M., Rudzki, Z., Giles, H. et al. (16 more authors) (2021) Management of allogeneic stem cell transplantation for high-risk AML following SARS-CoV-2 associated pancytopenia with marked bone marrow biopsy alterations. Case Reports in Hematology, 2021. 8843063. ISSN 2090-6560

Kanellopoulos, A. orcid.org/0000-0002-7400-5416, Ahmed, M.Z., Kishore, B. et al. (15 more authors) (2020) COVID‐19 in bone marrow transplant recipients : reflecting on a single centre experience. British Journal of Haematology, 190 (2). e67-e70. ISSN 0007-1048

Horgan, C., Kanellopoulos, A., Paneesha, S. et al. (3 more authors) (2019) A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant. Hematology Reports, 11 (1). 7800. ISSN 2038-8322